| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems
|
Härmark, Linda
|
|
2015
|
|
4 |
p. 337-347
|
artikel
|
| 2 |
Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children
|
Wang, Zixuan
|
|
2018
|
|
4 |
p. 499-513
|
artikel
|
| 3 |
Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®
|
Ampadu, Haggar H.
|
|
2016
|
|
4 |
p. 335-345
|
artikel
|
| 4 |
Adverse Drug Reactions in the Paediatric Population in Denmark
|
Aagaard, Lise
|
|
2010
|
|
4 |
p. 327-339
|
artikel
|
| 5 |
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study
|
Ogar, Comfort K.
|
|
|
|
4 |
p. 357-370
|
artikel
|
| 6 |
A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project
|
Roque Pereira, Leonardo
|
|
|
|
4 |
p. 333-344
|
artikel
|
| 7 |
Aminoglycosides in Septic Shock
|
Boyer, Alexandre
|
|
2013
|
|
4 |
p. 217-230
|
artikel
|
| 8 |
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System
|
Golomb, Beatrice A.
|
|
2018
|
|
4 |
p. 403-413
|
artikel
|
| 9 |
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
|
Verden, Abril
|
|
2017
|
|
4 |
p. 357-361
|
artikel
|
| 10 |
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study
|
Arnaud, Mickael
|
|
2017
|
|
4 |
p. 377-387
|
artikel
|
| 11 |
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
|
Burmester, Gerd R.
|
|
|
|
4 |
p. 379-392
|
artikel
|
| 12 |
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases
|
Ferrajolo, Carmen
|
|
2016
|
|
4 |
p. 305-315
|
artikel
|
| 13 |
Antimicrobials and the Risk of Torsades de Pointes
|
Poluzzi, Elisabetta
|
|
2010
|
|
4 |
p. 303-314
|
artikel
|
| 14 |
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
|
Dos Santos, Gaël
|
|
|
|
4 |
p. 365-375
|
artikel
|
| 15 |
Application of a Self-Controlled Case Series Study to a Database Study in Children
|
Ueyama, Hanae
|
|
2014
|
|
4 |
p. 259-268
|
artikel
|
| 16 |
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
|
Vitezic, Dinko
|
|
|
|
4 |
p. 255-265
|
artikel
|
| 17 |
Artificial Intelligence and the Future of the Drug Safety Professional
|
Danysz, Karolina
|
|
2018
|
|
4 |
p. 491-497
|
artikel
|
| 18 |
Assessing Opioid Shopping Behaviour
|
Cepeda, M. Soledad
|
|
2012
|
|
4 |
p. 325-334
|
artikel
|
| 19 |
Assessment of a New Instrument for Detecting Preventable Adverse Drug Reactions
|
Benkirane, Raja
|
|
2014
|
|
4 |
p. 383-393
|
artikel
|
| 20 |
Attributing Hyponatraemia to Treatment with Antipsychotic Medications
|
Josiassen, Richard C.
|
|
2011
|
|
4 |
p. 353-354
|
artikel
|
| 21 |
Authors’ Reply to Alain Braillon’s Comment on “Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France’’
|
Auffret, Marine
|
|
2017
|
|
4 |
p. 361-362
|
artikel
|
| 22 |
Authors’ Reply to Alain Braillon’s Comment on “The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project”
|
Raschi, Emanuel
|
|
2016
|
|
4 |
p. 367-368
|
artikel
|
| 23 |
Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
|
Raschi, Emanuel
|
|
|
|
4 |
p. 505-506
|
artikel
|
| 24 |
Authors’ Response to Huang et al.’s Comment on “Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance”
|
Bu, Fan
|
|
|
|
4 |
p. 403-404
|
artikel
|
| 25 |
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study
|
Bergman, Jorieke E. H.
|
|
2017
|
|
4 |
p. 415-427
|
artikel
|
| 26 |
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones
|
Motola, Domenico
|
|
2012
|
|
4 |
p. 315-323
|
artikel
|
| 27 |
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
|
Thai-Cuarto, Dao
|
|
2017
|
|
4 |
p. 429-440
|
artikel
|
| 28 |
Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs
|
Sacchetti, Emilio
|
|
2010
|
|
4 |
p. 273-288
|
artikel
|
| 29 |
Clinical Diagnosis
|
Edwards, I. Ralph
|
|
2012
|
|
4 |
p. 261-264
|
artikel
|
| 30 |
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose
|
Raethke, Monika
|
|
|
|
4 |
p. 391-404
|
artikel
|
| 31 |
Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
|
Giugliano, Robert P.
|
|
|
|
4 |
p. 503-504
|
artikel
|
| 32 |
Comment on: “Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France”
|
Braillon, Alain
|
|
2017
|
|
4 |
p. 359-360
|
artikel
|
| 33 |
Comment on “Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance”
|
Huang, Wan-Ting
|
|
|
|
4 |
p. 401-402
|
artikel
|
| 34 |
Comment on ‘The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project’
|
Braillon, Alain
|
|
2016
|
|
4 |
p. 365
|
artikel
|
| 35 |
Communicating About Risks and Safe Use of Medicines
|
Edwards, I. Ralph
|
|
|
|
4 |
p. 499-501
|
artikel
|
| 36 |
Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania
|
Barry, Abbie
|
|
|
|
4 |
p. 339-350
|
artikel
|
| 37 |
Comparative Performance of Two Drug Interaction Screening Programmes Analysing a Cross-Sectional Prescription Dataset of 84,625 Psychiatric Inpatients
|
Zorina, Olesya I.
|
|
2013
|
|
4 |
p. 247-258
|
artikel
|
| 38 |
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA
|
Weaver, James
|
|
|
|
4 |
p. 479-497
|
artikel
|
| 39 |
Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension
|
O’Connell, Caroline
|
|
2016
|
|
4 |
p. 287-294
|
artikel
|
| 40 |
Conference on Advances in Pharmacovigilance for Herbal Medicines 12th–14th April 2023
|
|
|
|
|
4 |
p. 419-431
|
artikel
|
| 41 |
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy
|
Cohen, Eric B.
|
|
|
|
4 |
p. 321-332
|
artikel
|
| 42 |
Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method
|
Gray, Matthew P.
|
|
|
|
4 |
p. 389-398
|
artikel
|
| 43 |
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update
|
Moore, Nicholas
|
|
|
|
4 |
p. 301-318
|
artikel
|
| 44 |
Correction to: A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project
|
Pereira, Leonardo Roque
|
|
|
|
4 |
p. 399
|
artikel
|
| 45 |
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
|
Kompa, Benjamin
|
|
|
|
4 |
p. 433
|
artikel
|
| 46 |
Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer
|
Petousis-Harris, Helen
|
|
|
|
4 |
p. 507
|
artikel
|
| 47 |
Correction to: Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
|
Singh, Tina
|
|
|
|
4 |
p. 401
|
artikel
|
| 48 |
Correction to: 19th ISoP Annual Meeting “New Opportunities for New Generations” Bogotá, Colombia, 26–29 October, 2019
|
|
|
|
|
4 |
p. 509
|
artikel
|
| 49 |
Deriving Dose Limits for Warnings in Electronic Prescribing Systems
|
Coleman, Jamie J.
|
|
2012
|
|
4 |
p. 291-298
|
artikel
|
| 50 |
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
|
Kant, Agnes
|
|
|
|
4 |
p. 319-331
|
artikel
|
| 51 |
Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic Review
|
Singh, Sonal
|
|
2018
|
|
4 |
p. 515-527
|
artikel
|
| 52 |
Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis
|
Zhang, Chen
|
|
2017
|
|
4 |
p. 285-292
|
artikel
|
| 53 |
Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll
|
Prada-Ramallal, Guillermo
|
|
2016
|
|
4 |
p. 351-358
|
artikel
|
| 54 |
Does Melatonin Affect Epileptic Seizures?
|
Jain, Siddharth
|
|
2013
|
|
4 |
p. 207-215
|
artikel
|
| 55 |
Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population
|
Eriksson, Robert
|
|
2014
|
|
4 |
p. 237-247
|
artikel
|
| 56 |
Dose Variations Associated with Formulations of NSAID Prescriptions for Children
|
Star, Kristina
|
|
2011
|
|
4 |
p. 307-317
|
artikel
|
| 57 |
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
|
Drent, Marjolein
|
|
|
|
4 |
p. 355-363
|
artikel
|
| 58 |
Drug-Induced Cardiac Arrhythmias
|
Doig, J. Colin
|
|
|
|
4 |
p. 265-275
|
artikel
|
| 59 |
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative
|
Cohen, Eric B.
|
|
|
|
4 |
p. 301-319
|
artikel
|
| 60 |
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
|
Rindi, Lorenzo Vittorio
|
|
|
|
4 |
p. 333-354
|
artikel
|
| 61 |
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data
|
Yamamoto, Hiroki
|
|
|
|
4 |
p. 371-389
|
artikel
|
| 62 |
Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention
|
Brandenburg, Nancy A.
|
|
2017
|
|
4 |
p. 333-341
|
artikel
|
| 63 |
Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study
|
Leone, Roberto
|
|
2013
|
|
4 |
p. 267-276
|
artikel
|
| 64 |
Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance
|
Edwards, Brian
|
|
2012
|
|
4 |
p. 265-271
|
artikel
|
| 65 |
Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines
|
Hartigan-Go, Kenneth
|
|
2015
|
|
4 |
p. 329-335
|
artikel
|
| 66 |
Erratum to: Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
|
Okonkwo, Rose I.
|
|
2016
|
|
4 |
p. 369
|
artikel
|
| 67 |
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts
|
Pierce, Carrie E.
|
|
2016
|
|
4 |
p. 317-331
|
artikel
|
| 68 |
Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit
|
Wong, Adrian
|
|
2018
|
|
4 |
p. 573-579
|
artikel
|
| 69 |
Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit
|
Wong, Adrian
|
|
|
|
4 |
p. 573-579
|
artikel
|
| 70 |
Evaluation of the Risk of Inflammatory Bowel Disease after the HPV Vaccination in Primary Care in Spain: A Time-Varying Cohort Analysis of Around 390,000 Girls
|
Martín-Merino, Elisa
|
|
|
|
4 |
p. 455-466
|
artikel
|
| 71 |
Exploring the Role of Guidelines in Contributing to Medication Errors: A Descriptive Analysis of National Patient Safety Incident Data
|
Jones, Matthew D.
|
|
|
|
4 |
p. 389-400
|
artikel
|
| 72 |
First, Catch Your Signal!
|
Edwards, I. Ralph
|
|
2010
|
|
4 |
p. 257-260
|
artikel
|
| 73 |
Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis
|
Gorelik, Einat
|
|
2018
|
|
4 |
p. 529-538
|
artikel
|
| 74 |
French Pharmacovigilance Public System and COVID-19 Pandemic
|
Grandvuillemin, Aurélie
|
|
|
|
4 |
p. 405-408
|
artikel
|
| 75 |
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
|
de Vries, Esther
|
|
|
|
4 |
p. 369-378
|
artikel
|
| 76 |
Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)
|
Kennedy, Kaitlin E.
|
|
|
|
4 |
p. 363-369
|
artikel
|
| 77 |
Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports
|
Trippe, Zahra Anita
|
|
2017
|
|
4 |
p. 293-303
|
artikel
|
| 78 |
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends
|
Ly, Nelly F.
|
|
|
|
4 |
p. 405-416
|
artikel
|
| 79 |
Incidence of Adverse Events Among Healthcare Workers Following H1N1 Mass Immunization in Ghana
|
Ankrah, Daniel N. A.
|
|
2013
|
|
4 |
p. 259-266
|
artikel
|
| 80 |
Individual Case Safety Reports —How to Determine the Onset Date of an Adverse Reaction
|
Klepper, Michael J.
|
|
2011
|
|
4 |
p. 299-305
|
artikel
|
| 81 |
Influence of Pharmacists’ Attitudes on Adverse Drug Reaction Reporting
|
Herdeiro, Maria T.
|
|
2006
|
|
4 |
p. 331-340
|
artikel
|
| 82 |
Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis
|
Boven, Job F. M. van
|
|
2013
|
|
4 |
p. 231-236
|
artikel
|
| 83 |
Initiatives to Identify and Mitigate Medication Errors in England
|
Cousins, David
|
|
2015
|
|
4 |
p. 349-357
|
artikel
|
| 84 |
Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data
|
von Osmanski, Benedikte Irene
|
|
|
|
4 |
p. 379-388
|
artikel
|
| 85 |
Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase®
|
Vogel, Ulrich
|
|
|
|
4 |
p. 351-362
|
artikel
|
| 86 |
ISoP Fellowships: Recognising and Promoting Leaders in Pharmacovigilance
|
McCarthy, Deirdre
|
|
|
|
4 |
p. 403-404
|
artikel
|
| 87 |
ISoP Fellowships: Recognising Contributions to the Goals of ISoP
|
McCarthy, Deirdre
|
|
|
|
4 |
p. 297-300
|
artikel
|
| 88 |
Isotretinoin Use and Compliance with the Dutch Pregnancy Prevention Programme
|
Teichert, Martina
|
|
2010
|
|
4 |
p. 315-326
|
artikel
|
| 89 |
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
|
Crisafulli, Salvatore
|
|
|
|
4 |
p. 343-355
|
artikel
|
| 90 |
Is There Still a Role for Desmopressin in Children with Primary Monosymptomatic Nocturnal Enuresis?
|
Walle, Johan Van de
|
|
2010
|
|
4 |
p. 261-271
|
artikel
|
| 91 |
Long-Term Treatment with Atypical Antipsychotics and the Risk of Weight Gain
|
Gentile, Salvatore
|
|
2006
|
|
4 |
p. 303-319
|
artikel
|
| 92 |
Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
|
Mayer, Lori
|
|
2017
|
|
4 |
p. 347-356
|
artikel
|
| 93 |
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
|
Cheng, Ning
|
|
2017
|
|
4 |
p. 363-376
|
artikel
|
| 94 |
Mometasone Furoate Nasal Spray
|
Zitt, Myron
|
|
|
|
4 |
p. 317-326
|
artikel
|
| 95 |
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence
|
Moneer, Osman
|
|
|
|
4 |
p. 305-318
|
artikel
|
| 96 |
Patient Experiences of Serious Adverse Drug Reactions and Their Attitudes to Medicines
|
Butt, Tehreem F.
|
|
2011
|
|
4 |
p. 319-328
|
artikel
|
| 97 |
Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
|
Schreuder, Nanno
|
|
|
|
4 |
p. 319-328
|
artikel
|
| 98 |
Performance of Probabilistic Method to Detect Duplicate Individual Case Safety Reports
|
Tregunno, Philip Michael
|
|
2014
|
|
4 |
p. 249-258
|
artikel
|
| 99 |
Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases
|
Seabroke, Suzie
|
|
2016
|
|
4 |
p. 355-364
|
artikel
|
| 100 |
Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
|
Wedemeyer, Ralph-Steven
|
|
2014
|
|
4 |
p. 201-211
|
artikel
|
| 101 |
Pharmacovigilance is … Vigilance
|
Edwards, I. Ralph
|
|
2015
|
|
4 |
p. 281-285
|
artikel
|
| 102 |
Pharmacovigilance of Herbal Medicines: Current State and Future Directions
|
|
|
2006
|
|
4 |
p. 341-370
|
artikel
|
| 103 |
Postoperative Respiratory Events in Surgical Patients Exposed to Opioid Analgesic Shortages Compared to Fully Matched Patients Non-exposed to Shortages
|
Rodriguez-Monguio, Rosa
|
|
|
|
4 |
p. 359-367
|
artikel
|
| 104 |
Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition
|
Lin, Minjie
|
|
2014
|
|
4 |
p. 213-224
|
artikel
|
| 105 |
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
|
Tetteh, Raymond A.
|
|
2017
|
|
4 |
p. 273-283
|
artikel
|
| 106 |
Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
|
Kaplan, Sigal
|
|
|
|
4 |
p. 345-357
|
artikel
|
| 107 |
Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
|
Weersink, Rianne A.
|
|
2018
|
|
4 |
p. 539-546
|
artikel
|
| 108 |
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22
|
France, Harrison S.
|
|
|
|
4 |
p. 335-342
|
artikel
|
| 109 |
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System
|
Moore, Nicholas
|
|
2018
|
|
4 |
p. 559-572
|
artikel
|
| 110 |
Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature
|
Nualdaisri, Pitchaya
|
|
|
|
4 |
p. 421-437
|
artikel
|
| 111 |
Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline
|
Tonstad, Serena
|
|
2010
|
|
4 |
p. 289-301
|
artikel
|
| 112 |
Quantitative Risk–Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease
|
Bennett, William E.
|
|
2015
|
|
4 |
p. 295-305
|
artikel
|
| 113 |
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015
|
Albogami, Yasser
|
|
|
|
4 |
p. 447-454
|
artikel
|
| 114 |
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
|
Bauchau, Vincent
|
|
|
|
4 |
p. 327-333
|
artikel
|
| 115 |
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR
|
Pierce, Carrie E.
|
|
2019
|
|
4 |
p. 477-489
|
artikel
|
| 116 |
Risk Management for the 21st Century: Current Status and Future Needs
|
Mouchantaf, Rania
|
|
|
|
4 |
p. 409-419
|
artikel
|
| 117 |
Risk Minimization Activities of Centrally Authorized Products in the EU
|
Zomerdijk, Inge M.
|
|
2012
|
|
4 |
p. 299-314
|
artikel
|
| 118 |
Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink
|
Bloechliger, Marlene
|
|
2015
|
|
4 |
p. 307-321
|
artikel
|
| 119 |
Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus
|
Setkina, Svetlana
|
|
|
|
4 |
p. 365-372
|
artikel
|
| 120 |
Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus
|
Setkina, Svetlana
|
|
2015
|
|
4 |
p. 365-372
|
artikel
|
| 121 |
Safety Consequences of Off-Label Drugs Used for COVID-19
|
Dasgupta, Nabarun
|
|
|
|
4 |
p. 399-402
|
artikel
|
| 122 |
Safety Monitoring of a New Pentavalent Vaccine in the Expanded Programme on Immunisation in Ghana
|
Dodoo, Alexander N.O.
|
|
|
|
4 |
p. 347-356
|
artikel
|
| 123 |
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
|
FitzGerald, J. Mark
|
|
|
|
4 |
p. 467-478
|
artikel
|
| 124 |
Safety of Drug Therapies Used for Weight Loss and Treatment of Obesity
|
Ioannides-Demos, Lisa L.
|
|
2006
|
|
4 |
p. 277-302
|
artikel
|
| 125 |
Safety of Flecainide
|
Tamargo, Juan
|
|
2012
|
|
4 |
p. 273-289
|
artikel
|
| 126 |
Safety of Herbal Products in Thailand
|
Saokaew, Surasak
|
|
2011
|
|
4 |
p. 339-350
|
artikel
|
| 127 |
Safety of Human Papillomavirus Vaccines: An Updated Review
|
Phillips, Anastasia
|
|
2017
|
|
4 |
p. 329-346
|
artikel
|
| 128 |
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
|
McNaughton, Rhian
|
|
2016
|
|
4 |
p. 323-333
|
artikel
|
| 129 |
Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England
|
Davies, Miranda
|
|
2013
|
|
4 |
p. 237-246
|
artikel
|
| 130 |
Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre Study
|
Schmiedl, Sven
|
|
2014
|
|
4 |
p. 225-235
|
artikel
|
| 131 |
Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database
|
Wahab, Izyan A.
|
|
2016
|
|
4 |
p. 347-354
|
artikel
|
| 132 |
Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?
|
Knowles, Sandra
|
|
|
|
4 |
p. 239-247
|
artikel
|
| 133 |
Signal Detection Based on Time to Onset Algorithm in Spontaneous Reporting System of China
|
Zhang, Tianyi
|
|
2017
|
|
4 |
p. 343-350
|
artikel
|
| 134 |
Social Media and Networks in Pharmacovigilance
|
Edwards, I. Ralph
|
|
2011
|
|
4 |
p. 267-271
|
artikel
|
| 135 |
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study
|
Muñoz, Monica A.
|
|
|
|
4 |
p. 377-387
|
artikel
|
| 136 |
Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance
|
Basch, Ethan
|
|
2013
|
|
4 |
p. 277-278
|
artikel
|
| 137 |
Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda
|
Ndagije, Helen
|
|
2015
|
|
4 |
p. 395-408
|
artikel
|
| 138 |
Thalidomide Use in the US
|
Uhl, Kathleen
|
|
2006
|
|
4 |
p. 321-329
|
artikel
|
| 139 |
The Authors’ Reply
|
Meulendijks, Didier
|
|
2011
|
|
4 |
p. 354-355
|
artikel
|
| 140 |
The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments
|
Yang, Wen-Wen
|
|
|
|
4 |
p. 289-299
|
artikel
|
| 141 |
The DIANA Study: Continued Access to Darunavir/Ritonavir (DRV/r) and Long-Term Safety Follow-Up in HIV-1-Infected Pediatric Patients Aged 3 to < 18 Years
|
Violari, Avy
|
|
|
|
4 |
p. 439-446
|
artikel
|
| 142 |
The Impact in Japan of Regulatory Action on Prescribing of Dopamine Receptor Agonists
|
Ooba, Nobuhiro
|
|
2011
|
|
4 |
p. 329-338
|
artikel
|
| 143 |
The Monitoring Medicines Project: A Multinational Pharmacovigilance and Public Health Project
|
Pal, Shanthi N.
|
|
2015
|
|
4 |
p. 319-328
|
artikel
|
| 144 |
The Rationale for Robust Pharmacovigilance in Monitoring the Safety of Traditional Medicines and Natural Health Products
|
Braund, Rhiannon
|
|
|
|
4 |
p. 417-418
|
artikel
|
| 145 |
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products
|
Smith, Meredith Y.
|
|
2017
|
|
4 |
p. 389-401
|
artikel
|
| 146 |
The Role of Computerized Decision Support in Reducing Errors in Selecting Medicines for Prescription
|
Baysari, Melissa T.
|
|
2011
|
|
4 |
p. 289-298
|
artikel
|
| 147 |
The Role of European Patient Organizations in Pharmacovigilance
|
Matos, Cristiano
|
|
2018
|
|
4 |
p. 547-557
|
artikel
|
| 148 |
The Safety of Generic Prescription Drugs in the United States
|
Singh, Sonal
|
|
2018
|
|
4 |
p. 325-328
|
artikel
|
| 149 |
The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
|
Hoffman, Keith B.
|
|
2014
|
|
4 |
p. 283-294
|
artikel
|
| 150 |
Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals
|
Gourbil, Mathilde
|
|
2014
|
|
4 |
p. 269-282
|
artikel
|
| 151 |
Today’s Challenges in Pharmacovigilance
|
Ebbers, Hans C.
|
|
2011
|
|
4 |
p. 273-287
|
artikel
|
| 152 |
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility
|
Muñoz, Monica A.
|
|
|
|
4 |
p. 329-338
|
artikel
|
| 153 |
User-Driven Development of a Web-Based Tool for Patient Reporting of Drug-Related Harm
|
Plöen, Monica
|
|
2015
|
|
4 |
p. 359-364
|
artikel
|
| 154 |
Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions
|
Knezevic, Marinela Z.
|
|
2011
|
|
4 |
p. 351-352
|
artikel
|
| 155 |
Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
|
Juhlin, Kristina
|
|
2015
|
|
4 |
p. 373-382
|
artikel
|
| 156 |
Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record
|
Yeboah-Korang, Amoah
|
|
|
|
4 |
p. 371-377
|
artikel
|
| 157 |
Vaccine-Based Subgroup Analysis in VigiBase
|
Bie, Sandra de
|
|
2012
|
|
4 |
p. 335-346
|
artikel
|
| 158 |
Vaccines and Guillain-Barré Syndrome
|
Haber, Penina
|
|
|
|
4 |
p. 309-323
|
artikel
|
| 159 |
Vulnerable Patients and Potential Harms: The Contribution of Observational Research
|
Layton, Deborah
|
|
2016
|
|
4 |
p. 277-280
|
artikel
|
Tijdschrift beschrijving